Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
david.priestman@pharm.ox.ac.uk

Telephone
+44 (0)1865 281116

Research groups

Platt Laboratory | Lysosomal and Sphingolipid Disorders

David Priestman

Senior Research Fellow

Recent publications

Glucosamine Amends CNS Pathology in Mucopolysaccharidosis IIIC Mouse Expressing Misfolded HGSNAT
Journal article

PLATT F., (2022), Journal of Clinical Investigation
Glycosphingolipid metabolism and its role in ageing and Parkinson's disease.
Journal article

Wallom K-L. et al, (2021), Glycoconj J
An iPSC model of Hereditary Sensory Neuropathy type-1 reveals Serine responsive deficits in neuronal ganglioside composition and axoglial interactions
Journal article

CLARK A., (2021), Cell Reports Medicine
Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicity.
Journal article

PLATT F. and PRIESTMAN D., (2020), Acta Neuropathologica Communications
Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms.
Journal article

Viana GM. et al, (2020), J Clin Med, 9

More publications